Online Programme
Search for the sessions or presentations
PG 3.2 - How to perform MRI for Crohn’s perianal fistulas
Presentation Number
PG 3.2
Channel
Live streaming channel 1
Learning objectives
To learn anal and perianal anatomy on MRI
To know the sequences used for MRI of perianal fistulas
Collapse
[{"name":"PG 3.2 - How to perform MRI for Crohn\u2019s perianal fistulas","mode":"playlist","public":true,"info":{"id":52,"presentation":"PG 3.2 - How to perform MRI for Crohn\u2019s perianal fistulas","session":"PG 3 - Perianal Crohn\u2019s disease: all you need to know","presenter":"K. Horsthuis, Losser, NL","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/52_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/52_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/5B0ED5D2.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/52_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/52_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/8E22WM0U\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/8E22WM0U\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"8E22WM0U"}
[session]
[presentation]
[presenter]
Collapse
PG 3.3 - MRI of perianal fistulas: classification and disease activity
Presentation Number
PG 3.3
Channel
Live streaming channel 1
Learning objectives
To learn the classification of perianal fistulas
To become familiar with the MR imaging features of active perianal Crohn’s disease
To learn a systematic approach for interpreting and reporting MRI of perianal fistulas
Collapse
[{"name":"PG 3.3 - MRI of perianal fistulas: classification and disease activity","mode":"playlist","public":true,"info":{"id":53,"presentation":"PG 3.3 - MRI of perianal fistulas: classification and disease activity","session":"PG 3 - Perianal Crohn\u2019s disease: all you need to know","presenter":"A. Plumb, Esher, GB","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/53_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/53_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/97A4D54C.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/53_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/53_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/9E22WM0V\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/9E22WM0V\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"9E22WM0V"}
[session]
[presentation]
[presenter]
Collapse
PG 3.4 - Case based discussion
Presentation Number
PG 3.4
Channel
Live streaming channel 1
[{"name":"PG 3.4 - Case based discussion","mode":"playlist","public":true,"info":{"id":54,"presentation":"PG 3.4 - Case based discussion","session":"PG 3 - Perianal Crohn\u2019s disease: all you need to know","presenter":"J. Stoker, Amsterdam, NL, S. Taylor, London, GB","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/54_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/54_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/9D61DC55.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/54_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/6\/v\/54_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/aE22WM0W\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/aE22WM0W\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"aE22WM0W"}
[session]
[presentation]
[presenter]
Collapse
PG 4.1 - GI side effects of immunotherapy
Presentation Number
PG 4.1
Channel
On-demand channel 1
Learning objectives
To know the GI side effects of immunotherapy
To understand the rad-path correlation of GI imaging findings related to immunotherapy
To learn the imaging findings of GI side effects and complications from immunotherapy
Collapse
[{"name":"PG 4.1 - GI side effects of immunotherapy","mode":"playlist","public":true,"info":{"id":56,"presentation":"PG 4.1 - GI side effects of immunotherapy","session":"PG 4 - When GI immunity is at stake","presenter":"M. Gollub, New York, US, M. Chalabi, Amsterdam, NL","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/8\/v\/56_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/8\/v\/56_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/8\/25A2D798.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/8\/v\/56_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/8\/v\/56_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/7E22WM0Y\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/7E22WM0Y\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"7E22WM0Y"}
[session]
[presentation]
[presenter]
Collapse
PG 4.2 - GI side effects of chemotherapy
Presentation Number
PG 4.2
Channel
On-demand channel 1
Learning objectives
To know the GI side effects of chemotherapy
To understand the rad-path correlation of GI imaging findings related to chemotherapy
To learn the acute imaging features of neutropenic enterocolitis and the differential diagnosis
Collapse
PG 4.3 - GI manifestations of Graft versus Host Disease
Presentation Number
PG 4.3
Channel
On-demand channel 1
Learning objectives
To know the GI manifestations of Graft versus Host Disease (relevant to the radiologist)
To understand the rad-path correlation of GI imaging findings in Graft versus Host Disease
To learn the imaging findings of Graft versus Host Disease and its complications
Collapse
ET 2.2 - MR enterography in Crohn’s disease
Presentation Number
ET 2.2
Channel
On-demand channel 3
Learning objectives
To learn the optimal imaging protocol for small bowel evaluation
To learn how different imaging features correlate with endoscopic findings
To learn how to make a structured report
Collapse
ET 4.2 - Benign gallbladder diseases
Presentation Number
ET 4.2
Channel
On-demand channel 5
Learning objectives
To learn about the range of acute and chronic conditions that can affect the gallbladder
To learn about the role of different imaging techniques in the diagnosis of benign gallbladder disease
To be able to identify the imaging appearances of benign gallbladder disease and to know which features help to differentiate benign from malignant disease
Collapse
[{"name":"ET 4.2 - Benign gallbladder diseases","mode":"playlist","public":true,"info":{"id":74,"presentation":"ET 4.2 - Benign gallbladder diseases","session":"ET 4 - Benign gallbladder diseases #SINGLE TOPIC","presenter":"S. Sen, Kolkata, IN","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/14\/v\/74_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/14\/v\/74_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/14\/696CAC39.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/14\/v\/74_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/14\/v\/74_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/aE22WM02h\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/aE22WM02h\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"aE22WM02h"}
[session]
[presentation]
[presenter]
Collapse
ET 5.2 - Cholangiocarcinoma and mimics
Presentation Number
ET 5.2
Channel
On-demand channel 6
Learning objectives
To become familiar with the typical growth patterns and imaging findings of both intra- and extrahepatic cholangiocarcinoma
To learn about the prevalence and clinical implications of mixed hepatocellular-cholangiocellular carcinoma
To describe those biliary tumours and pseudotumours that mimic cholangiocarcinoma
Collapse
[{"name":"ET 5.2 - Cholangiocarcinoma and mimics","mode":"playlist","public":true,"info":{"id":76,"presentation":"ET 5.2 - Cholangiocarcinoma and mimics","session":"ET 5 - Cholangiocarcinoma and mimics #SINGLE TOPIC","presenter":"B. Op De Beeck, Edegem, BE","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/15\/v\/76_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/15\/v\/76_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/15\/F6DF72C1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/15\/v\/76_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/15\/v\/76_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/7E22WM02j\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/7E22WM02j\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"7E22WM02j"}
[session]
[presentation]
[presenter]
Collapse
GS 1.3 - ESGAR/SAR guideline quantification of diffuse liver diseases 2020
Presentation Number
GS 1.3
Channel
On-demand channel 1
US 1.1 - Contrast-enhanced abdominal US
Presentation Number
US 1.1
Channel
On-demand channel 8
Learning objectives
To understand how easy CEUS of the abdomen is to perform and why it should be practiced in any Radiology department
To learn the common and uncommon indications of abdominal CEUS
To appreciate its value as a problem-solving modality in the abdomen, by confirming or elucidating CT or MR findings, by skipping these examinations altogether, or by even reaching a diagnosis when these, more sophisticated, modalities fail to do so
Collapse
[{"name":"US 1.1 - Contrast-enhanced abdominal US","mode":"playlist","public":true,"info":{"id":585,"presentation":"US 1.1 - Contrast-enhanced abdominal US","session":"US 1 - Contrast-enhanced abdominal US","presenter":"D. Cokkinos, Athens, GR","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/96\/v\/585_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/96\/v\/585_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/96\/B033BAC6.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/96\/v\/585_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/96\/v\/585_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/6E22WM0b6\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/6E22WM0b6\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"6E22WM0b6"}
[session]
[presentation]
[presenter]
Collapse
ET 6.1 - Interventional treatment of HCC
Presentation Number
ET 6.1
Channel
On-demand channel 3
Learning objectives
To learn about the current options, indications and limitations of locoregional treatments for HCC
To become familiar with the assessment of treatment response after locoregional treatment
To understand the role of locoregional techniques in HCC treatment
Collapse
[{"name":"ET 6.1 - Interventional treatment of HCC","mode":"playlist","public":true,"info":{"id":89,"presentation":"ET 6.1 - Interventional treatment of HCC","session":"ET 6 - Interventional treatment of HCC #SINGLE TOPIC","presenter":"M. Vouche, Brussels, BE","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/18\/v\/89_1p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/18\/v\/89_1p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/18\/B76ACFC2.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/18\/v\/89_1p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/18\/v\/89_1p-thumbnails.vtt"}]}]
{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/aE22WM02x\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/aE22WM02x\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"aE22WM02x"}
[session]
[presentation]
[presenter]
Collapse